ALX Oncology Holdings Statistics

Total Valuation

ALXO has a market cap or net worth of $29.31 million. The enterprise value is -$51.93 million.

Market Cap	29.31M
Enterprise Value	-51.93M

Important Dates

The next confirmed earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

ALXO has 53.44 million shares outstanding. The number of shares has increased by 16.96% in one year.

Current Share Class	53.44M
Shares Outstanding	53.44M
Shares Change (YoY)	+16.96%
Shares Change (QoQ)	+1.05%
Owned by Insiders (%)	2.45%
Owned by Institutions (%)	40.91%
Float	31.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.33
P/TBV Ratio	0.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.47, with a Debt / Equity ratio of 0.19.

Current Ratio	5.47
Quick Ratio	5.27
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-79.93

Financial Efficiency

Return on equity (ROE) is -102.99% and return on invested capital (ROIC) is -59.69%.

Return on Equity (ROE)	-102.99%
Return on Assets (ROA)	-51.16%
Return on Invested Capital (ROIC)	-59.69%
Return on Capital Employed (ROCE)	-133.64%
Revenue Per Employee	n/a
Profits Per Employee	-$1.63M
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.67% in the last 52 weeks. The beta is 1.16, so ALXO's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-93.67%
50-Day Moving Average	0.51
200-Day Moving Average	1.26
Relative Strength Index (RSI)	54.68
Average Volume (20 Days)	450,776

Short Selling Information

The latest short interest is 5.69 million, so 10.65% of the outstanding shares have been sold short.

Short Interest	5.69M
Short Previous Month	5.83M
Short % of Shares Out	10.65%
Short % of Float	18.16%
Short Ratio (days to cover)	12.83

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-136.53M
Pretax Income	-166.20M
Net Income	-130.02M
EBITDA	-135.66M
EBIT	-136.53M
Earnings Per Share (EPS)	-$2.45

Full Income Statement

Balance Sheet

The company has $97.83 million in cash and $16.59 million in debt, giving a net cash position of $81.25 million or $1.52 per share.

Cash & Cash Equivalents	97.83M
Total Debt	16.59M
Net Cash	81.25M
Net Cash Per Share	$1.52
Equity (Book Value)	88.30M
Book Value Per Share	1.65
Working Capital	83.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$108.65 million and capital expenditures -$359,000, giving a free cash flow of -$109.01 million.

Operating Cash Flow	-108.65M
Capital Expenditures	-359,000
Free Cash Flow	-109.01M
FCF Per Share	-$2.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALXO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.96%
Shareholder Yield	-16.96%
Earnings Yield	-443.55%
FCF Yield	-371.87%

Analyst Forecast

The average price target for ALXO is $3.30, which is 501.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.30
Price Target Difference	501.64%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3